Markers of bowel inflammation

The symptoms of Irritable Bowel Syndrome (IBS) and Inflammatory Bowel Disease (IBD) can be very similar but they are two very different medical conditions. Historically gastroenterologists have had to use endoscopies to distinguish between the two disorders. Calprotectin tests are used to detect inflammation in the gut which may be caused by Inflammatory Bowel Disease such as Crohn's or ulcerative colitis, and thus can help distinguish between these conditions.

What we test


Calprotectin is a protein released by a type of white blood cell. When there is inflammation in the gastrointestinal tract, white blood cells move to the area and release calprotectin, resulting in an increased level in the stool.

This stool test measures:

This protein is released into the stool when the intestinal lining is damaged. It's usually very high in cases of Inflammatory Bowel Disease (such as Crohn's or ulcerative colitis), and low in IBS. Calprotectin is also elevated with gut infections and colon cancers.

Test instructions

Your test kit for your stool sample and all instructions are posted directly to you.

Results for this test available in 7 days and will be published in your online dashboard.

Ready. Set. Go!
Buy now for $110 AUD

You may also be interested in

Best sellerTest kit
Microbiome Check
32 tests included
$229 AUD
As well as analysing your beneficial and pathogenic bacteria, our comprehensive microbiome test also includes testing for parasites and yeast overgrowth, and also provides an assessment of your digestive markers. This holistic picture provides actionable insights to help you improve your gut health.
Test kit
2 tests included
$289 AUD
FODMAPs are naturally occurring sugars found in milk and dairy products, fruits and vegetables, cereals and processed foods. These dietary sugars are poorly absorbed in the gut and can cause symptoms of irritable bowel syndrome.
Bowel Screen Check
2 tests included
$65 AUD
Australia has one of the highest rates of bowel cancer in the world - 1 in 13 Australians will develop the disease in their lifetime. When identified early, 90% of bowel cancer cases can be successfully treated.